Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-22-059051

Director acquired 7,176 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kariv Tomer Director 2022-11-29 Option exercise −3,539 $0.00 $0 2,284,612 I: show line 1 in the form
Kariv Tomer Director 2022-11-29 Option exercise −1,723 $0.00 $0 1,121,045 I: show line 2 in the form
Kariv Tomer Director 2022-11-29 Option exercise −1,914 $0.00 $0 1,226,412 I: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kariv Tomer Director 2022-11-29 Option exercise · Call Options (obligation to sell) −3,539 0 I: show line 4 in the form
Kariv Tomer Director 2022-11-29 Option exercise · Call Options (obligation to sell) −1,723 0 I: show line 5 in the form
Kariv Tomer Director 2022-11-29 Option exercise · Call Options (obligation to sell) −1,914 0 I: show line 6 in the form
Loading xslF345X03/doc4.xml…